BCHE and Alzheimer disease: Recent advancements in quercetin derivatives, such as quercetin‐1,2,3‐triazole hybrids, have shown enhanced cholinesterase inhibition and antioxidant activity, surpassing standard drugs like galantamine, thus highlighting quercetin's potential in multitarget AD therapy (Carreiro et al. 2023).